UK News
-
UK to test mixed vaccine doses
More than 800 people in the UK will take part in the world’s first trial of mixing the two major kinds of COVID-19 vaccine in a £7 million study, it was announced today. Read more
-
Brain-related visual problem ‘common’ in children
Researchers are hoping to raise awareness of a brain-related visual impairment, which may be more common than previously believed. Read more
-
12 week vaccine booster delay unexpectedly effective
The British government gambled correctly when it decided to extend the interval for booster vaccine doses to 12 weeks, according to a significant new analysis. Read more
-
Antiviral drug may fight COVID-19
An antiviral drug based on a traditional Mediterranean remedy is showing promising results against COVID-19 infection, scientists have reported. Read more
-
Shorter radiotherapy course benefits bladder cancer patients
Fewer, but larger doses of radiation, reduce the risk of bladder cancer returning, according to a study published today. Read more
-
Virus variant study raises vaccine concerns
The SARS-COv-2 virus began mutating to avoid human immunity in the spring last year – raising concerns about the durability of the current vaccines, according to the findings of a major UK scientific study. Read more
-
Metformin may affect breast cancer risk
Metformin could affect a woman’s risk of developing breast cancer, a USA study published today has suggested. Read more
-
Support needed to make self isolation work
The UK Government must prioritise support, such as specialist accommodation, to enable people to self isolate after testing positive for COVID-19, infectious disease experts say today. Read more
-
Hope for end to melanoma rates growth
The growth in melanoma incidence in young adults has “stabilised” this century, suggesting that public health messages may have had some success, according to a new UK study. Read more
-
Sex differences in cardiovascular disease risk
Doctors often mistake the development of hypertension in women for symptoms of menopause, according to a new analysis. Read more
